ChengDa Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 102.2 million compared to CNY 108.62 million a year ago. Revenue was CNY 102.2 million compared to CNY 108.62 million a year ago.

Net income was CNY 19.64 million compared to CNY 26.23 million a year ago. Basic earnings per share from continuing operations was CNY 0.127 compared to CNY 0.1849 a year ago. Diluted earnings per share from continuing operations was CNY 0.127 compared to CNY 0.1849 a year ago.